Report Detail

Request for Sample of this report

Pharma & Healthcare Global Opioids Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2930112
    • |
  • 12 February, 2019
    • |
  • Global
    • |
  • 119 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Scope of the Report:
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Opioids Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Opioids Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other

Market Segment by Applications, can be divided into
Pain Relief
Anesthesia
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug in 2017 and 2018.
Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Opioids Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oxycodone
      • 1.2.2 Hydromorphone
      • 1.2.3 Codeine
      • 1.2.4 Fentanyl
      • 1.2.5 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pain Relief
      • 1.3.2 Anesthesia
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Purdue Pharma
      • 2.1.1 Business Overview
      • 2.1.2 Opioids Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 J&J
      • 2.2.1 Business Overview
      • 2.2.2 Opioids Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Teva
      • 2.3.1 Business Overview
      • 2.3.2 Opioids Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Opioids Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Depomed
      • 2.5.1 Business Overview
      • 2.5.2 Opioids Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Depomed Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 INSYS
      • 2.6.1 Business Overview
      • 2.6.2 Opioids Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Endo
      • 2.7.1 Business Overview
      • 2.7.2 Opioids Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Pfizer
      • 2.8.1 Business Overview
      • 2.8.2 Opioids Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Hikma
      • 2.9.1 Business Overview
      • 2.9.2 Opioids Drug Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Mallinckrodt
      • 2.10.1 Business Overview
      • 2.10.2 Opioids Drug Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Pernix
      • 2.11.1 Business Overview
      • 2.11.2 Opioids Drug Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Pernix Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Egalet
      • 2.12.1 Business Overview
      • 2.12.2 Opioids Drug Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Vistapharm
      • 2.13.1 Business Overview
      • 2.13.2 Opioids Drug Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Vistapharm Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Opioids Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Opioids Drug Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Opioids Drug Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Opioids Drug Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Opioids Drug Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Opioids Drug Market Analysis by Regions

    • 4.1 Global Opioids Drug Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Opioids Drug Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Opioids Drug Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Opioids Drug Sales and Growth Rate (2014-2019)
    • 4.3 Europe Opioids Drug Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Opioids Drug Sales and Growth Rate (2014-2019)
    • 4.5 South America Opioids Drug Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Opioids Drug Sales and Growth Rate (2014-2019)

    5 North America Opioids Drug by Country

    • 5.1 North America Opioids Drug Sales, Revenue and Market Share by Country
      • 5.1.1 North America Opioids Drug Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Opioids Drug Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Opioids Drug Sales and Growth Rate (2014-2019)
    • 5.3 Canada Opioids Drug Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Opioids Drug Sales and Growth Rate (2014-2019)

    6 Europe Opioids Drug by Country

    • 6.1 Europe Opioids Drug Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Opioids Drug Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Opioids Drug Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Opioids Drug Sales and Growth Rate (2014-2019)
    • 6.3 UK Opioids Drug Sales and Growth Rate (2014-2019)
    • 6.4 France Opioids Drug Sales and Growth Rate (2014-2019)
    • 6.5 Russia Opioids Drug Sales and Growth Rate (2014-2019)
    • 6.6 Italy Opioids Drug Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Opioids Drug by Country

    • 7.1 Asia-Pacific Opioids Drug Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Opioids Drug Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Opioids Drug Revenue and Market Share by Country (2014-2019)
    • 7.2 China Opioids Drug Sales and Growth Rate (2014-2019)
    • 7.3 Japan Opioids Drug Sales and Growth Rate (2014-2019)
    • 7.4 Korea Opioids Drug Sales and Growth Rate (2014-2019)
    • 7.5 India Opioids Drug Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Opioids Drug Sales and Growth Rate (2014-2019)

    8 South America Opioids Drug by Country

    • 8.1 South America Opioids Drug Sales, Revenue and Market Share by Country
      • 8.1.1 South America Opioids Drug Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Opioids Drug Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Opioids Drug Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Opioids Drug Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Opioids Drug Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Opioids Drug by Countries

    • 9.1 Middle East and Africa Opioids Drug Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Opioids Drug Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Opioids Drug Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Opioids Drug Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Opioids Drug Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Opioids Drug Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Opioids Drug Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Opioids Drug Sales and Growth Rate (2014-2019)

    10 Global Opioids Drug Market Segment by Type

    • 10.1 Global Opioids Drug Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Opioids Drug Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Opioids Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Oxycodone Sales Growth and Price
      • 10.2.1 Global Oxycodone Sales Growth (2014-2019)
      • 10.2.2 Global Oxycodone Price (2014-2019)
    • 10.3 Hydromorphone Sales Growth and Price
      • 10.3.1 Global Hydromorphone Sales Growth (2014-2019)
      • 10.3.2 Global Hydromorphone Price (2014-2019)
    • 10.4 Codeine Sales Growth and Price
      • 10.4.1 Global Codeine Sales Growth (2014-2019)
      • 10.4.2 Global Codeine Price (2014-2019)
    • 10.5 Fentanyl Sales Growth and Price
      • 10.5.1 Global Fentanyl Sales Growth (2014-2019)
      • 10.5.2 Global Fentanyl Price (2014-2019)
    • 10.6 Other Sales Growth and Price
      • 10.6.1 Global Other Sales Growth (2014-2019)
      • 10.6.2 Global Other Price (2014-2019)

    11 Global Opioids Drug Market Segment by Application

    • 11.1 Global Opioids Drug Sales Market Share by Application (2014-2019)
    • 11.2 Pain Relief Sales Growth (2014-2019)
    • 11.3 Anesthesia Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Opioids Drug Market Forecast (2019-2024)

    • 12.1 Global Opioids Drug Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Opioids Drug Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Opioids Drug Market Forecast (2019-2024)
      • 12.2.2 Europe Opioids Drug Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Opioids Drug Market Forecast (2019-2024)
      • 12.2.4 South America Opioids Drug Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Opioids Drug Market Forecast (2019-2024)
    • 12.3 Opioids Drug Market Forecast by Type (2019-2024)
      • 12.3.1 Global Opioids Drug Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Opioids Drug Market Share Forecast by Type (2019-2024)
    • 12.4 Opioids Drug Market Forecast by Application (2019-2024)
      • 12.4.1 Global Opioids Drug Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Opioids Drug Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Opioids Drug . Industry analysis & Market Report on Opioids Drug is a syndicated market report, published as Global Opioids Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Opioids Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,686.56
      		4,029.84
      		5,373.12
      		3,201.60
      		4,802.40
      		6,403.20
      		530,108.40
      		795,162.60
      		1,060,216.80
      		292,772.40
      		439,158.60
      		585,544.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo